Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SANDOSTATIN for Carcinoid tumour: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 6 adverse event reports in the FDA FAERS database where SANDOSTATIN was used for Carcinoid tumour.

Most Reported Side Effects for SANDOSTATIN

Side Effect Reports % Deaths Hosp.
Death 27 37.5% 27 14
Diarrhoea 13 18.1% 9 6
Malaise 13 18.1% 5 6
Abdominal pain 12 16.7% 7 9
Nausea 12 16.7% 6 8
Asthenia 11 15.3% 7 9
Fatigue 11 15.3% 7 7
General physical health deterioration 10 13.9% 6 7
Vomiting 10 13.9% 7 7
Back pain 9 12.5% 7 6
Weight decreased 9 12.5% 6 8
Injection site pain 8 11.1% 6 4
Pain 8 11.1% 4 4
Blood pressure increased 7 9.7% 4 5
Drug ineffective 7 9.7% 2 1

Other Indications for SANDOSTATIN

Off label use (14) Neuroendocrine tumour (12)

Other Drugs Used for Carcinoid tumour

OCTREOTIDE (2,148) TELOTRISTAT ETHYL (1,281) LANREOTIDE (496) EVEROLIMUS (270) SUNITINIB MALATE (61) LENALIDOMIDE (60) CABOZANTINIB S-MALATE (56) CAPECITABINE (50) TIPIRACIL\TRIFLURIDINE (36) SANDOSTATIN LAR (34)

Related Pages

SANDOSTATIN Full Profile All Carcinoid tumour Drugs SANDOSTATIN Demographics SANDOSTATIN Timeline